{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T05:47:49Z","timestamp":1696398469019},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00508-013-0403-6","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T10:09:30Z","timestamp":1379326170000},"page":"591-599","source":"Crossref","is-referenced-by-count":7,"title":["Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study"],"prefix":"10.1007","volume":"125","author":[{"given":"Lucia","family":"R\u00f6ssler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina Collas","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsyarina","family":"Holl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar A.","family":"Joura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"403_CR1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890\u2013907.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"403_CR2","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","volume":"32","author":"JG Baseman","year":"2005","unstructured":"Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(Suppl 1):S16\u201324.","journal-title":"J Clin Virol"},{"key":"403_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"403_CR4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2559.2007.02652.x","volume":"50","author":"S Regauer","year":"2007","unstructured":"Regauer S, Reich O. CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology. 2007;50(5):629\u201335.","journal-title":"Histopathology"},{"key":"403_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/LGT.0b013e31806dba20","volume":"12","author":"O Reich","year":"2008","unstructured":"Reich O, Pickel H, Regauer S. Why does HPV infection induce sharply demarcated lesions of the cervix? J Low Genit Tract Dis. 2008;12:8\u201310.","journal-title":"J Low Genit Tract Dis"},{"key":"403_CR6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00004347-200210000-00013","volume":"21","author":"O Reich","year":"2002","unstructured":"Reich O, Pickel H. Multifocal stromal invasion in microinvasive squamous cell carcinoma of the cervix: how to measure and stage these lesions. Int J Gynecol Pathol. 2002;21:416\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"403_CR7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0029-7844(01)01358-8","volume":"97","author":"O Reich","year":"2001","unstructured":"Reich O, Pickel H, Tamussino K, Winter R. Microcarcinoma of the cervix: first focus of invasion. Obstet Gynecol. 2001;97:890\u20132.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"403_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425\u201334.","journal-title":"Lancet Oncol"},{"key":"403_CR9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621\u201332.","journal-title":"Int J Cancer"},{"key":"403_CR10","doi-asserted-by":"crossref","unstructured":"Tjalma WA, Fiander A, Reich O, et al.; HERACLES\/SCALE Study Group. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer. 2013;132(4):854\u201367.","DOI":"10.1002\/ijc.27713"},{"issue":"8","key":"403_CR11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857\u201372.","journal-title":"Stat Med"},{"key":"403_CR12","unstructured":"Zechmeister I. \u00d6konomische Evaluation der Impfung gegen humane Papillomaviren (HPV- Impfung) in \u00d6sterreich. Endbericht des Ludwig Boltzmann Instituts f\u00fcr Health Technology Assessment (LBI-HTA) 2007;26."},{"key":"403_CR13","unstructured":"Leitner B. Statistik Austria, Jahrbuch der Gesundheitsstatistik 2010. Vienna: Statistik Austria; 2011."},{"issue":"9509","key":"403_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","volume":"367","author":"M Kyrgiou","year":"2006","unstructured":"Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489\u201398.","journal-title":"Lancet"},{"key":"403_CR15","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","volume":"337","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337:a1284.","journal-title":"BMJ"},{"issue":"1","key":"403_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2012.01.019","volume":"162","author":"M Hentenryck Van","year":"2012","unstructured":"Van Hentenryck M, Noel JC, Simon P. Obstetric and neonatal outcome after surgical treatment of cervical dysplasia. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):16\u201320.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"403_CR17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-0528.2009.02438.x","volume":"117","author":"G Ortoft","year":"2010","unstructured":"Ortoft G, Henriksen T, Hansen E, Petersen L. After conisation of the cervix, the perinatal mortality as a result of preterm delivery increases in subsequent pregnancy. BJOG. 2010;117(3):258\u201367.","journal-title":"BJOG"},{"issue":"21\u201322","key":"403_CR18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00508-008-1093-3","volume":"120","author":"L Six","year":"2008","unstructured":"Six L, Leodolter S, Sings HL, Barr E, Haupt R, Joura EA. Prevalence of Human Papillomavirus Types 6, 11, 16, and 18 in young Austrian Women- the baseline data of a Phase III Vaccine Trial. Wien Klin Wochenschr. 2008;120(21\u201322):666\u201371.","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"403_CR19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajog.2007.08.055","volume":"197","author":"TJ Herzog","year":"2007","unstructured":"Herzog TJ, Monk BJ. Reducing the burden of glandular carcinomas of the uterine cervix. Am J Obstet Gynecol. 2007;197(6):566\u201371.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"403_CR20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray F, Carstensen B, M\u00f8ller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005;14(9):2191\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"403_CR21","unstructured":"Zielonke N. Krebsinzidenz und Krebsmortalit\u00e4t in \u00d6sterreich 2012. Vienna: Statistik Austria; 2012."},{"issue":"6","key":"403_CR22","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/ijc.25723","volume":"128","author":"KA Ault","year":"2011","unstructured":"Ault KA, Joura EA, Kjaer SK, et al.; FUTURE I and II Study Group. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. Int J Cancer. 2011;128(6):1344\u201353.","journal-title":"Int J Cancer"},{"issue":"6","key":"403_CR23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/ijc.25470","volume":"128","author":"MH Stoler","year":"2011","unstructured":"Stoler MH, Vichnin MD, Ferenczy A, et al.; FUTURE I, II and III Investigators. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer. 2011;128(6):1354\u201362.","journal-title":"Int J Cancer."},{"key":"403_CR24","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1128\/JCM.00539-06","volume":"44","author":"LJ Doorn van","year":"2006","unstructured":"van Doorn LJ, Molijn A, Kleter B, Quint W, Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol. 2006;44:3292\u20138.","journal-title":"J Clin Microbiol"},{"key":"403_CR25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/JCM.40.3.979-983.2002","volume":"40","author":"LJ Doorn van","year":"2002","unstructured":"van Doorn LJ, Quint W, Kleter B, et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J\u00a0Clin Microbiol. 2002;40:979\u201383.","journal-title":"J Clin Microbiol"},{"issue":"9686","key":"403_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmer\u00f3n J, et al.; HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301\u201314.","journal-title":"Lancet"},{"issue":"1","key":"403_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","volume":"13","author":"M Lehtinen","year":"2012","unstructured":"Lehtinen M, Paavonen J, Wheeler CM, et al.; HPV PATRICIA Study Group. Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):89\u201399.","journal-title":"Lancet Oncol"},{"key":"403_CR28","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"FUTURE II Study Group","year":"2007","unstructured":"FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915\u201327.","journal-title":"N Engl J Med"},{"key":"403_CR29","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","volume":"369","author":"EA Joura","year":"2007","unstructured":"Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three clinical trials. Lancet. 2007;369:1693\u2013702.","journal-title":"Lancet"},{"key":"403_CR30","doi-asserted-by":"crossref","unstructured":"Joura EA, Garland SM, Paavonen J, et al.; FUTURE I and II Study Group. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ. 2012;27(344):e1401.","DOI":"10.1136\/bmj.e1401"},{"issue":"7","key":"403_CR31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","volume":"199","author":"DR Brown","year":"2009","unstructured":"Brown DR, Kjaer SK, Sigurdsson K, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326 years. J Infect Dis. 2009;199(7):926\u201335.","journal-title":"J Infect Dis"},{"issue":"1","key":"403_CR32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2012","unstructured":"Wheeler CM, Castellsagu\u00e9 X, Garland SM, et al. HPV PATRICIA Study Group. Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):100\u201310.","journal-title":"Lancet Oncol"},{"issue":"10","key":"403_CR33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","volume":"12","author":"T Malag\u00f3n","year":"2012","unstructured":"Malag\u00f3n T, Drolet M, Boily MC, et al. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(10):781\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"403_CR34","doi-asserted-by":"crossref","first-page":"F157","DOI":"10.1016\/j.vaccine.2012.06.091","volume":"30","author":"K Canfell","year":"2012","unstructured":"Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ. Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine. 2012;30 Suppl 5:F157\u201367.","journal-title":"Vaccine."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-013-0403-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0403-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:53:34Z","timestamp":1559094814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-013-0403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,17]]},"references-count":34,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1007\/s00508-013-0403-6","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,17]]}}}